Literature DB >> 2612748

Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis.

M Caselli1, P Pazzi, R LaCorte, A Aleotti, L Trevisani, G Stabellini.   

Abstract

A histological study was performed in order to evaluate the prevalence of Campylobacter-like organisms (CLO) and gastric antral lesions in 85 rheumatoid arthritis (RA) patients using NSAIDs, and in 100 nonrheumatoid outpatients comparable in terms of sex and age, not using NSAIDs. Histological evidence of gastritis was a common finding both in RA patients (88.2%) and in nonrheumatoid outpatients (89.0%). On the other hand, CLO were detected in a significantly lower proportion (p less than 0.001) of RA patients than outpatients (30.6 and 59.0%, respectively). Considering each NSAID used separately (aspirin, diclofenac sodium and ketoprofen), no significant difference in the presence of CLO in the three groups was found; in the small group of patients treated with aspirin, however, bacteria were never detected. MICs of each NSAID used against 15 isolates of Campylobacter pylori were also determined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612748     DOI: 10.1159/000199898

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  18 in total

Review 1.  Antimicrobial Effects of Antipyretics.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 2.  Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.

Authors:  R La Corte; M Caselli; G Castellino; G Bajocchi; F Trotta
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

3.  Celecoxib inhibits Helicobacter pylori colonization-related factors.

Authors:  Jing Wang; Wei-Hong Wang; Jiang Li; Fang-Xun Liu
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

4.  Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.

Authors:  A S Taha; R I Russell
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

5.  Histological findings in gastric mucosa in patients treated with non-steroidal anti-inflammatory drugs.

Authors:  M Caselli; R LaCorte; L DeCarlo; A Aleotti; L Trevisani; M Ruina; F Trotta; V Alvisi
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

6.  Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man.

Authors:  G R Lipscomb; N Wallis; G Armstrong; M J Goodman; W D Rees
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

7.  Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; J Reid; P Boothmann; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

8.  Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; S Dahill; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

9.  Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study.

Authors:  K Shah; A B Price; I C Talbot; K D Bardhan; C G Fenn; I Bjarnason
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

10.  Diagnostic tests for Helicobacter pylori: comparison and influence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; P Boothman; I Nakshabendi; J Reid; C Morran; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.